Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation-Reference-Cited by-同舟云学术

Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation

Published:2018-01-31 Issue:6 Volume:36 Page:889-895
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Tanimoto Ryuta,Saika Takashi,Ebara Shin,Kobayashi Yasuyuki,Nasu Ryoji,Yamada Daisuke,Takamoto Hitoshi,Miyaji Yoshiyuki,Nasu Yasutomo,Tsushima Tomoyasu,Kumon Hiromi

Funder

OURG

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-018-2196-8/fulltext.html

Reference18 articles.

1. Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S, De Nunzio C, Okamura K, Kaasinen E, Solsona E, Ali-El-Dein B, Tatar CA, Inman BA, N’Dow J, Oddens JR, Babjuk M (2016) Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol 69(2):231–244. https://doi.org/10.1016/j.eururo.2015.05.050

2. Kang M, Jeong CW, Kwak C, Kim HH, Ku JH (2016) Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs. Oncotarget 7(29):45479–45488. https://doi.org/10.18632/oncotarget.9991

3. De Nunzio C, Carbone A, Albisinni S, Alpi G, Cantiani A, Liberti M, Tubaro A, Iori F (2011) Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial. World J Urol 29(4):517–521. https://doi.org/10.1007/s00345-011-0691-2

4. Gudjonsson S, Adell L, Merdasa F, Olsson R, Larsson B, Davidsson T, Richthoff J, Hagberg G, Grabe M, Bendahl PO, Mansson W, Liedberg F (2009) Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study. Eur Urol 55(4):773–780. https://doi.org/10.1016/j.eururo.2009.01.006

5. Barghi MR, Rahmani MR, Hosseini Moghaddam SM, Jahanbin M (2006) Immediate intravesical instillation of mitomycin C after transurethral resection of bladder tumor in patients with low-risk superficial transitional cell carcinoma of bladder. Urol J 3(4):220–224

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse;AAPS PharmSciTech;2024-09-07

2. Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer;Cancers;2023-04-26

3. Efficacy of compound aluminum sulfate injection as a monotherapeutic regimen in non-muscle invasive bladder cancer patients: a retrospective single-arm cohort study;Translational Andrology and Urology;2022-09

4. Nicht-muskelinvasives Harnblasenkarzinom (NMIBC) – Rezidivprophylaxe bei geringem und intermediärem Risiko;Der Urologe;2021-10-15

5. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study);Trials;2021-02-12